Contact Breaking Barriers
AGT-182 – Hunter Syndrome (MPS 2) Clinical Trials

Have questions or concerns about the Breaking Barriers Hunter Syndrome Trial? Submit them below and the Breaking Barriers team will respond back as soon as possible. Interested in participating in the trial? Find Study Locations >>









  • TO QUALIFY,
    YOU MUST BE:

    • Ages 18 or older.
    • ​Diagnosed with Hunter Syndrome.
    • Available for 8 weeks of investigational treatment.
    • Willing to discontinue standard enzyme replacement therapy and switch to AGT-182 for the duration of their participation in the clinical trial.
  • Inquire about the
    clinical trial: